Global Stem Cell Technologies and Applications Market 2017-2027
Cancer, Cardiovascular, CNS, Other Disease Areas and Non-Therapeutic Applications
LONDON, May 16, 2017 /PRNewswire/ -- Report Details
The global stem cell technologies and applications market is expected to grow at a CAGR of 13.4% in the first half of the forecast period and CAGR of 10.5% in the second half of the forecast period. The market is expected to grow at a CAGR of 11.7% from 2016 to 2027. The market is estimated at $10,751 million in 2016 and $17,768 million in 2020.
Download the full report: https://www.reportbuyer.com/product/4890877/
How this report will benefit you
Read on to discover how you can exploit the future business opportunities emerging in this sector.
In this brand new 257-page report you will receive 114 charts – all unavailable elsewhere.
The 257-page report provides clear detailed insight into the global stem cell technologies and applications market. Discover the key drivers and challenges affecting the market.
By ordering and reading our brand new report today you stay better informed and ready to act.
Report Scope
• Global Stem Cell Technologies and Applications Market forecasts from 2017-2027
• Global Stem Cell Technologies and Applications submarket forecasts from 2017-2027:
- Cancer treatment
- Cardiovascular therapy
- CNS
- Other therapies
- Non-therapeutic applications
• Individual revenue forecast to 2027 for selected top products:
- MSC-100-IV (Mesoblast)
- Hearticellgram-AMI (Pharmicell)
- CardioRel (Reliance Life Sciences)
- Osteocel Plus (NuVasive)
- Trinity Evolution and Elite (Orthofix)
- CARTISTEM (MEDIPOST)
• Analysis of the most promising pipeline therapies in each therapeutic segment
• Discussion on regulatory environments and developments in the US, Japan, Europe and other leading countries
• Analysis of what drives and restrains the market
• This study also discusses other influences on that field, including these:
- Haematopoietic stem cell transplantation (HSCT)
- Embryonic stem cells (ESCs), induced pluripotent adult (IPSCs) and parthenogenetic cells
- Uses for umbilical cord blood and related technologies, including cellular and blood banking
- Agents for osteogenesis and treating autoimmune conditions
- Applications in cell-based assays, diagnostics and drug development.
Download the full report: https://www.reportbuyer.com/product/4890877/
About Reportbuyer
Reportbuyer is a leading industry intelligence solution that provides all market research reports from top publishers
http://www.reportbuyer.com
For more information:
Sarah Smith
Research Advisor at Reportbuyer.com
Email: [email protected]
Tel: +44 208 816 85 48
Website: www.reportbuyer.com
SOURCE ReportBuyer
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article